VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...
—Late-breaking BIOADAPTOR RCT data to highlight two-year clinical outcomes of the DynamX Bioadaptor, the first therapy designed to restore coronary artery hemodynamic modulation and improve PCI ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation (PNS) System utilizing their ...
A large U.S. randomized trial published in the New England Journal of Medicine found that etomidate, compared with ketamine, ...
Targeted indoor residual spraying focuses insecticide applications on common resting surfaces of Aedes aegypti mosquitoes (an arboviral disease vector) in houses, such as exposed lower sections of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback